NASDAQ:CTNM | Free Cash Flow | Contineum Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$16.27M$312,000.00-$16.58M
2025-12-31-$13.04M$42,000.00-$13.08M
2025-03-31-$14.41M$47,000.00-$14.46M
2024-12-31-$10.2M$166,000.00-$10.37M
2024-03-31-$7.98M$147,000.00-$8.12M
2023-12-31-$10.7M$309,000.00-$11.01M
2023-03-31-$5.24M$52,000.00-$5.3M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$55.31M$231,000.00-$55.54M
2024-12-31-$32.85M$514,000.00-$33.36M
2023-12-31$19.35M$414,000.00$18.94M83.34%